Clinical Trial: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501559) titled 'A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)' on March 16.

Brief Summary: The goal of this clinical trial is to evaluate the safety and efficacy of JL15003 Injection in subjects with recurrent glioblastoma (rGMB).

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Recurrent Glioblastoma Multiforme(GBM)

Intervention: BIOLOGICAL: JL15003Injection

Intratumoral or intracavitary administration of JL15003 Injection as needed

Recruitment Status: RECRUITING

Sponsor: Jecho Biopharmaceuticals Co., Ltd.

Published by HT Digital Co...